EpicentRx, Inc.
EpicentRx, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer | Digestive System Diseases, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Stomatognathic Diseases, carcinoma, digestive system disorder, epithelial neoplasm, gastroenteritis, mouth disorder, mucositis, neoplasm, squamous cell carcinoma, squamous cell neoplasm, stomatitis | Active, not recruiting | Phase 2 | 2026-06-26 | NCT05966194 | |
| A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors | DNA Virus Infections, Infections, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, adenoviridae infectious disease, cancer, chondrosarcoma, connective tissue neoplasm, neoplasm, sarcoma, viral infectious disease | Active, not recruiting | Phase 2 | 2026-06-26 | NCT04673942 | |
| A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Active, not recruiting | Phase 3 | 2024-10-31 | NCT05566041 |